Schroder Investment Management Group Ionis Pharmaceuticals Inc Transaction History
Schroder Investment Management Group
- $101 Billion
- Q4 2024
A detailed history of Schroder Investment Management Group transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 100,659 shares of IONS stock, worth $3.39 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,659
Previous 56,222
79.04%
Holding current value
$3.39 Million
Previous $2.25 Million
56.26%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding IONS
# of Institutions
399Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$554 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$477 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$386 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$347 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$265 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.78B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...